14-103126654-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006291.4(TNFAIP2):c.197C>A(p.Ala66Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000778 in 1,556,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006291.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFAIP2 | NM_006291.4 | c.197C>A | p.Ala66Asp | missense_variant | 2/12 | ENST00000560869.6 | NP_006282.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFAIP2 | ENST00000560869.6 | c.197C>A | p.Ala66Asp | missense_variant | 2/12 | 5 | NM_006291.4 | ENSP00000452634 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000420 AC: 64AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000101 AC: 16AN: 158574Hom.: 0 AF XY: 0.0000592 AC XY: 5AN XY: 84526
GnomAD4 exome AF: 0.0000399 AC: 56AN: 1403776Hom.: 0 Cov.: 31 AF XY: 0.0000419 AC XY: 29AN XY: 692692
GnomAD4 genome AF: 0.000427 AC: 65AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.197C>A (p.A66D) alteration is located in exon 1 (coding exon 1) of the TNFAIP2 gene. This alteration results from a C to A substitution at nucleotide position 197, causing the alanine (A) at amino acid position 66 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at